Quick Links
About myPNHteam
Powered By
Below is a listing of treatments and therapies for PNH. Click on one to read more information or connect with others currently using it.
Overview
PiaSky is approved by the U.S. Food and Drug Administration (FDA) for the treatment of paroxysmal nocturnal hemoglobinuria (PNH) in adults and children 13 years and older who weigh at least 40 kilograms (around…
Overview
Soliris is approved by the U.S. Food and Drug Administration (FDA) to treat people with paroxysmal nocturnal hemoglobinuria (PNH). Soliris is prescribed for individuals with PNH to reduce hemolysis (destruction…
Overview
Ultomiris is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat people 1 month or older with paroxysmal nocturnal hemoglobinuria (PNH). Ultomiris is also referred to by its… read more
Overview
Voydeya is approved by the U.S. Food and Drug Administration (FDA) as an add-on therapy to either ravulizumab or eculizumab for the treatment of extravascular hemolysis (destruction of red blood cells outside of…
Sign up for free!
Continue with Facebook
Sign up with your email
Your privacy is our priority.
Join